Search results
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 7 days agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...
The deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...